- 全部删除
- 您的购物车当前为空
Sdz 210-096 is a novel opiate antagonist. It is a novel 14 beta-benzyl morphinan derivative with antagonistic actions at mu and kappa opiate receptors. This compound has been characterized for luteinizing hormone (LH) secretion-stimulating effects in a variety of experimental paradigms in the rat.
Sdz 210-096 is a novel opiate antagonist. It is a novel 14 beta-benzyl morphinan derivative with antagonistic actions at mu and kappa opiate receptors. This compound has been characterized for luteinizing hormone (LH) secretion-stimulating effects in a variety of experimental paradigms in the rat.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 | |
100 mg | 询价 | 10-14周 |
产品描述 | Sdz 210-096 is a novel opiate antagonist. It is a novel 14 beta-benzyl morphinan derivative with antagonistic actions at mu and kappa opiate receptors. This compound has been characterized for luteinizing hormone (LH) secretion-stimulating effects in a variety of experimental paradigms in the rat. |
分子量 | 401.54 |
分子式 | C27H31NO2 |
CAS No. | 109026-86-0 |
存储 | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容